Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Myeroff

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2000
Detection of TGF-beta type II receptor hot-spot mutations: the BAT-RII assayL L Myeroff, S Markowitz
Journal of the National Cancer Institute|January 20, 1993
Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potentialL L Myeroff, S D Markowitz
Journal of the National Cancer Institute|December 21, 1994
Nm23--into the basement (membrane)L L Myeroff, S D Markowitz
Gastroenterology|January 1, 1997
What's new with RII?W Grady, A Rajput, L Myeroff, et al.
Methods in Molecular Medicine|February 15, 2011
Mutation Detection inTGF-β ReceptorsW M Grady, L L Myeroff, H He, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2000
Mutation detection in the TGF-beta receptors and smad genes: RT-PCR and sequencingL L Myeroff, H He, S P Fink, et al.
Cancer Research|July 29, 1998
Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomasW M Grady, A Rajput, L Myeroff, et al.
The Journal of Clinical Investigation|March 1, 1994
A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor geneS D Markowitz, L Myeroff, M J Cooper, et al.
Cancer Research|December 1, 1995
Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancerR Parsons, L L Myeroff, B Liu, et al.
The Journal of Biological Chemistry|September 15, 1995
Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cellsJ Wang, L Sun, L Myeroff, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2000
Detection of TGF-beta type II receptor hot-spot mutations: the BAT-RII assayL L Myeroff, S Markowitz
Journal of the National Cancer Institute|January 20, 1993
Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potentialL L Myeroff, S D Markowitz
Journal of the National Cancer Institute|December 21, 1994
Nm23--into the basement (membrane)L L Myeroff, S D Markowitz
Gastroenterology|January 1, 1997
What's new with RII?W Grady, A Rajput, L Myeroff, et al.
Methods in Molecular Medicine|February 15, 2011
Mutation Detection inTGF-β ReceptorsW M Grady, L L Myeroff, H He, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2000
Mutation detection in the TGF-beta receptors and smad genes: RT-PCR and sequencingL L Myeroff, H He, S P Fink, et al.
Cancer Research|July 29, 1998
Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomasW M Grady, A Rajput, L Myeroff, et al.
The Journal of Clinical Investigation|March 1, 1994
A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor geneS D Markowitz, L Myeroff, M J Cooper, et al.
Cancer Research|December 1, 1995
Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancerR Parsons, L L Myeroff, B Liu, et al.
The Journal of Biological Chemistry|September 15, 1995
Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cellsJ Wang, L Sun, L Myeroff, et al.
Pageof 2